Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DART-II: d4T XR + 3TC + EFV in ART-Naive HIV
NCT00116116Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2002
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of stavudine in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Started Mar 2002; status: completed.
02
Drugs
stavudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00116116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116116.